Botulinum toxin examined for depression.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 7, p. 7
- Publication type:
- Article
Works matching IS 10685308 AND DT 2012 AND VI 23 AND IP 7
Results: 11
1
2
Discontinued antidepressant worsens outcomes in dementia patients.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 7, p. 4
- Publication type:
- Article
3
Risperidone-induced tardive Pisa syndrome.
- Published in:
- 2012
- Publication type:
- Case Study
4
Long-acting stimulant reduces collision rates of young adult drivers with ADHD.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 7, p. 8
- Publication type:
- Article
5
Modafinil added to risperidone for chronic schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 7, p. 7
- Publication type:
- Article
6
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 7, p. 8
- Publication type:
- Article
7
Antipsychotic exposure affects neurodevelopment in infants.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 7, p. 3
- Publication type:
- Article
8
Use of statins associated with lower depression risk*.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 7, p. 3
- Publication type:
- Article
9
High venlafaxine serum level found after prior fluoxetine treatment.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
10
Brain-injured see fast recovery in 4-week trial of amantadine.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 7, p. 1
- Publication type:
- Article
11
Glucocorticoids increase risk of suicidal behavior and psychiatric disorders.
- Published in:
- Brown University Psychopharmacology Update, 2012, v. 23, n. 7, p. 1
- Publication type:
- Article